These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24298447)

  • 1. Correlates of NNAL levels among nondaily and daily smokers in the college student population.
    Berg CJ; Schauer GL; Ahluwalia JS; Benowitz NL
    Curr Biomark Find; 2012 Oct; 2012(2):. PubMed ID: 24298447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample.
    Khariwala SS; Scheuermann TS; Berg CJ; Hayes RB; Nollen NL; Thomas JL; Guo H; Ahluwalia JS; Benowitz NL
    Nicotine Tob Res; 2014 May; 16(5):600-5. PubMed ID: 24297808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
    Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
    J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
    Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
    Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents.
    Jacob P; St Helen G; Yu L; Nardone N; Havel C; Cheung P; Benowitz NL
    Nicotine Tob Res; 2020 Jun; 22(7):1107-1113. PubMed ID: 31833541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial.
    Mercincavage M; Lochbuehler K; Wileyto EP; Benowitz NL; Tyndale RF; Lerman C; Strasser AA
    JAMA Netw Open; 2018 Aug; 1(4):e181346. PubMed ID: 30627706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
    Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of and reasons for using multiple other tobacco products in daily and nondaily smokers: Associations with cigarette consumption and nicotine dependence.
    Dunbar MS; Shadel WG; Tucker JS; Edelen MO
    Drug Alcohol Depend; 2016 Nov; 168():156-163. PubMed ID: 27664553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.
    Chaffee BW; Jacob P; Couch ET; Benowitz NL
    Nicotine Tob Res; 2020 Oct; 22(10):1764-1771. PubMed ID: 31504879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
    Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
    J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Goniewicz ML; Havel CM; Peng MW; Jacob P; Dempsey D; Yu L; Zielinska-Danch W; Koszowski B; Czogala J; Sobczak A; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3421-5. PubMed ID: 19959691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed cutoff for identifying adult smokeless tobacco users with urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol: an aggregated analysis of NHANES 2007-2010 data.
    Agaku IT; Vardavas CI; Connolly G
    Nicotine Tob Res; 2013 Nov; 15(11):1956-61. PubMed ID: 23956252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
    J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
    Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.
    Piper ME; Baker TB; Benowitz NL; Kobinsky KH; Jorenby DE
    Nicotine Tob Res; 2019 Aug; 21(9):1279-1284. PubMed ID: 30365010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.
    Radwan G; Hecht SS; Carmella SG; Loffredo CA
    Nicotine Tob Res; 2013 Jan; 15(1):130-8. PubMed ID: 22573723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.